Zynex, Inc. to Postpone Fourth Quarter and Full Year 2022 Financial Results Release and Conference Call

Rhea-AI Summary

Zynex, Inc. (NASDAQ: ZYXI) announced the postponement of its fourth quarter and full year 2022 financial results and conference call originally scheduled for March 6, 2023. The company aims to allow more time for year-end closing procedures. The specific date for the rescheduled announcement will be provided in a future press release.

Zynex specializes in non-invasive medical devices for pain management, rehabilitation, and patient monitoring. Founded in 1996, the company continues to innovate in the medical technology sector.

Positive

• None.

Negative

• Postponement of financial results may indicate potential internal issues or delays in financial reporting.
• Investors may perceive the delay negatively, leading to uncertainty regarding the company's financial health.

News Market Reaction – ZYXI

-21.35%

-21.35% Session move

In the trading session that priced this news, ZYXI declined 21.35%, reflecting a significant negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ENGLEWOOD, Colo., March 6, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that the company will postpone the release of its fourth quarter and full year financial results and conference call initially scheduled for Monday, March 6, 2023 at 4:15 p.m. ET.

The company will announce its fourth quarter and full year 2022 financial results and conference call schedule in a future press release to allow additional time to complete its year-end closing procedures.

About Zynex, Inc.
Zynex, founded in 1996, develops, manufacturers, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis and laser-based pulse oximetry monitoring systems for use in hospitals. For additional information, please visit: www.zynex.com

Contact: Zynex, Inc. (800) 495-6670

Investor Relations Contact:
Gilmartin Group
Investor Relations Counsel
ir@zynex.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/zynex-inc-to-postpone-fourth-quarter-and-full-year-2022-financial-results-release-and-conference-call-301763794.html

SOURCE Zynex

FAQ

What caused Zynex to postpone its financial results release on March 6, 2023?

Zynex stated that the postponement allows additional time to complete its year-end closing procedures.

When will Zynex announce its fourth quarter and full year 2022 financial results?

The specific date for the rescheduled announcement will be provided in a future press release.

How does the postponement of financial results affect Zynex investors?

The delay may create uncertainty among investors about the company's financial health and performance.

What is Zynex's main focus in the medical technology sector?

Zynex specializes in the manufacture and sale of non-invasive medical devices for pain management and rehabilitation.